期刊文献+

45例儿童急性淋巴细胞性白血病流式细胞术免疫分型的研究 被引量:1

Investigation of immunophenotype in 45 cases of children with acute lymphoblastic leukemia via flow cytometry
下载PDF
导出
摘要 目的研究儿童急性淋巴细胞性白血病(ALL)免疫表型的特点。方法采用流式细胞仪对45例初治儿童急性淋巴细胞性白血病进行免疫表型分析。结果①45例ALL中T淋巴细胞性ALL(T-ALL)5例(11.1%),B淋巴细胞性ALL(B-ALL)36例(79.9%);ALL1型(L1)9例(20%),ALL2型(L2)27例(60%),ALL3型(L3)5例(11.1%);②45例ALL中4例符合急性混合性白血病(HAL)的诊断标准(8.9%),25例(55.6%)为髓系抗原阳性的ALL(My+ALL),其中CD13阳性率最多,为44.4%(20例),CD33为22.2%(10例),CD15为22.2%(10例)。B-ALL中My阳性率为55.6%,T-ALL中My阳性率为20%,有明显差异;L1中My阳性率为22.2%(2/9),L2中My阳性率为70.4%(19/27),L3中My阳性率为40%(2/5),L2中My阳性率明显高于L1和L3(P<0.05)。结论结合免疫表型分析与细胞形态学检验能为儿童急性淋巴细胞性白血病的诊断提供更可靠和更有价值的分型依据。 Objective To study the character of immunophenotype in children with acute lymphoblastic leukemia(ALL).Methods To assay the immunophenotype in 45 children with acute leukemia by flow cytometer.Results ① In 45 cases ALL T-ALL was 11.1%,B-ALL was 79.9%;ALL1 20%,ALL2 60.0%,ALL3 11.1%;② In 45 cases ALL,four children was diagnosed HAL by immunophenotype and the positive rate of myeloid antigen was 55.6%.While the positive rate of CD13 was 44.4%,CD33 was 22.2%,CD15 was 22.2%,respectively.The positive rate of myeloid antigen in B-ALL(55.6%) was significantly higher compare with T-ALL(20%)(P<0.05);the positive rate of myeloid antigen in L2(70.4%) was significant higher than in L1(22.2%) and L3(40%)(P<0.05).Conclusion Immunophenotyping,combined with morphology can provide more reliable and valuable evidence in the diagnosis of children with lymphoblastic leukemia.
出处 《分子诊断与治疗杂志》 2009年第4期255-257,共3页 Journal of Molecular Diagnostics and Therapy
关键词 白血病 淋巴细胞 急性 儿童 流式细胞术 Leukemia Lymphoblastic Acute Children Flow cytometry
  • 相关文献

参考文献14

二级参考文献36

  • 1汤美华,王琦.127例儿童急性淋巴细胞白血病免疫表型特点[J].中华儿科杂志,1993,31(4):218-220. 被引量:6
  • 2王玉龙,李筱骏,顾龙君.儿童急性淋巴细胞白血病的免疫表型与预后的关系[J].中华血液学杂志,1996,17(2):70-72. 被引量:19
  • 3Bain B J, Barnett D, Linch D, et al.Revised guideline on immunophenotyping in acute leukaemias and chronic lymphoproliferative disorders. Clin Lab Haematol, 2002; 24: 1-13
  • 4Mason DY, Cordell JL, Brown MH, et al. CD79a: a novel marker for B-cell neoplasms in routinely processed tissue samples.Blood, 1995; 86: 1453-1459
  • 5Chu PG, Arber DA. CD79: a review. Appl Immunohistochem Mol Morphol, 2001; 9:97-106
  • 6Piedras J, Barrales-Benitez O, Lopez-Karpovitch X. Classification of acute leukemias according to the first latin-american consensus conference for the immunophenotyping ofleukemias. Rev Invest Clin, 2000; 52: 524-528
  • 7Kaleem Z, Crawford E, Pathan MH, et al. Flow cytometric analysis of acute leukemias.Diagnostic utility and critical analysis of data. Arch Pathol Lab Med, 2003; 127:42-48
  • 8Pilozzi E, Pulford K, Jones M, et al. Co-expression of CD79a (JCB 117) and CD3 by Lymphoblastic lymphoma. J Pathol, 1998;186:140-143
  • 9Hashirnoto M, Yamashita Y, Mori N, et al. Immunohistochemical detection CD79a of expression in precursor T cell lymphoblastic lymphoma/leukemias. J Pathol, 2002; 197 :341-347
  • 10Sartor M, Bradstock K. Detection of intracellular lymphoid differentiation antigens byflow cytometry in acute lymphoblastic leukemia. Cytometry, 1994; 18:119-122

共引文献40

同被引文献5

  • 1顾龙君.儿童急性淋巴细胞白血病诊疗建议(第三次修订草案)[J].中华儿科杂志,2006,44(5):392-395. 被引量:477
  • 2Gomyo H, Shimoyama M, Minagawa K, et al. Morphologic, flow cytometric and cytogenetic evaluation of bone marrow involvement in B - cell lymphoma[ J]. Haematologica, 2003,88 (12) : 1358 - 1365.
  • 3Pui C H, Scherappem, Ribeiro R C, et al. Childhood and adolescent lymphoid and myeloid leukemia [ J ]. Hematology Am Soc Hemetal Edue Program ,2004,21 ( 2 ) : 118 - 145.
  • 4Harara M, Soda Y, Tani K, et al. CD19 -targeting liposomes containing imatinib efficiently kill Philadelphia chromosome - positive acute lymphoblastic leukemia cells [ J ]. Blood, 2004,104 ( 5 ) : 1442 - 1449.
  • 5蔡耘,陈惠芹,李晓峰,窦娟,王清文,何政贤.111例儿童急性淋巴细胞白血病免疫分型与临床研究[J].中国热带医学,2009,9(6):1039-1041. 被引量:5

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部